Year archive

EXACT Therapeutics AS — 2022 filings

All 31 regulatory filings released by EXACT Therapeutics AS (EXTX) in 2022, sourced directly from the official regulator.

31 Filings

2022 Period

2022 filings (31)

Filing	Released	Lang
Exact Therapeutics awarded NOK 16 million from Norwegian Research Council for collaboration project with NTNU, ICR and TGen Capital/Financing Update	2022-12-22	Norwegian
Exact Therapeutics awarded NOK 16 million from Norwegian Research Council for collaboration project with NTNU, ICR and TGen Capital/Financing Update	2022-12-22	English
EXACT Therapeutics and TGen publish preclinical data on Acoustic Cluster Therapy combined with chemotherapy in a pancreatic cancer model Regulatory Filings	2022-11-22	English
EXACT Therapeutics and TGen publish preclinical data on Acoustic Cluster Therapy combined with chemotherapy in a pancreatic cancer model Regulatory Filings	2022-11-22	English
EXACT Therapeutics AS – Mandatory notification of trade in connection with grant of options to CEO - with attachment Director's Dealing	2022-09-30	English
EXACT Therapeutics AS – Mandatory notification of trade in connection with grant of options to CEO - with attachment Director's Dealing	2022-09-30	English
EXACT Therapeutics AS – Mandatory notification of trade in connection with grant of options to CEO Director's Dealing	2022-09-30	English
EXACT Therapeutics AS announces interim results for first half 2022 Interim / Quarterly Report H1 2022	2022-09-22	English
EXACT Therapeutics AS announces interim results for first half 2022 Report Publication Announcement H1 2022	2022-09-22	English
EXACT Therapeutics announces appointment of Dr Amir Snapir as Chief Medical Officer Board/Management Information	2022-09-16	English
EXACT Therapeutics announces appointment of John Edminson as CFO Board/Management Information	2022-08-31	English
EXACT Therapeutics AS - Share Capital Increase Registered Share Issue/Capital Change	2022-07-04	English
EXACT Therapeutics AS - Share Capital Increase Registered Share Issue/Capital Change	2022-07-04	English
EXACT Therapeutics AS – Primary Insider Notice Director's Dealing	2022-06-09	English
EXACT Therapeutics AS – Primary Insider Notice Director's Dealing	2022-06-09	English
EXACT Therapeutics AS - Notice of Increase in Share Capital Share Issue/Capital Change	2022-06-09	English
EXACT Therapeutics AS announces appointment of Anders Wold as Chair of the Board Board/Management Information	2022-06-08	English
EXACT Therapeutics AS announces appointment of Anders Wold as Chair of the Board Board/Management Information	2022-06-08	English
EXACT Therapeutics AS: Minutes of Annual General Meeting 2022 AGM Information	2022-06-08	English
EXACT Therapeutics AS: Minutes of Annual General Meeting 2022 AGM Information	2022-06-08	English
EXACT Therapeutics AS to present at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference in Toronto Regulatory Filings	2022-06-01	English
EXACT Therapeutics AS to present at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference in Toronto Regulatory Filings	2022-06-01	English
EXACT Therapeutics AS - Notice of Annual General Meeting 2022 AGM Information	2022-05-30	English
EXACT Therapeutics AS - Notice of Annual General Meeting 2022 Annual Report FY 2021	2022-05-30	English
EXACT Therapeutics AS - Notice of Annual General Meeting 2022 AGM Information	2022-05-30	English
EXACT Therapeutics AS Board Update Board/Management Information	2022-05-19	English
EXACT Therapeutics AS Board Update Board/Management Information	2022-05-19	English
EXACT Therapeutics AS announces the publication of its 2021 Annual Report Report Publication Announcement	2022-04-27	English
EXACT Therapeutics AS Announces Appointment of Dr Per Walday as Chief Executive Officer Board/Management Information	2022-03-28	English
Exact Therapeutics Announces Clinical Trial Update Legal Proceedings Report	2022-03-08	English
Exact Therapeutics Announces Clinical Trial Update Regulatory Filings	2022-03-08	English